Recurrent pyoderma gangrenosum precipitated by breast cancer: a case report and review of the literature

od Duchnowska, Renata, Ziajka, Ewa, Góralska, Agnieszka, Grala, Bartłomiej
Izdano 2014

Molecular Profiles of Brain Metastases: A Focus on Heterogeneity

od Ali, Shan, Górska, Zuzanna, Duchnowska, Renata, Jassem, Jacek
Izdano u Cancers (Basel) (2021)

The role of Tau protein in resistance to paclitaxel

od Smoter, Marta, Bodnar, Lubomir, Duchnowska, Renata, Stec, Rafał, Grala, Bartłomiej, Szczylik, Cezary
Izdano 2011

Metastasis-Initiating Cells in Renal Cancer

od Khan, Mohammed I., Czarnecka, Anna M., Duchnowska, Renata, Kukwa, Wojciech, Szczylik, Cezary
Izdano 2013

Impact of relative dose intensity of oxaliplatin in adjuvant therapy among stage III colon cancer patients on early recurrence: a retrospective cohort study

od Żok, Jolanta, Bieńkowski, Michał, Radecka, Barbara, Korniluk, Jan, Adamowicz, Krzysztof, Duchnowska, Renata
Izdano u BMC Cancer (2021)

Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study

od Jurczak, Wojciech, Kalinka-Warzocha, Ewa, Chmielowska, Ewa, Duchnowska, Renata, Wojciechowska-Lampka, Elzbieta, Wieruszewska, Karolina
Izdano u Contemp Oncol (Pozn) (2015)

Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation

od Hryciuk, Beata, Szymanowski, Bartosz, Romanowska, Anna, Salt, Ewa, Wasąg, Bartosz, Grala, Bartłomiej, Jassem, Jacek, Duchnowska, Renata
Izdano u Oncol Lett (2018)

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer

od Hryciuk, Beata, Pęksa, Rafał, Bieńkowski, Michał, Szymanowski, Bartosz, Radecka, Barbara, Winnik, Kamil, Żok, Jolanta, Cichowska, Natalia, Iliszko, Mariola, Duchnowska, Renata
Izdano u Sci Rep (2020)

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of...

od Pęksa, Rafał, Kunc, Michał, Popęda, Marta, Piątek, Michał, Bieńkowski, Michał, Żok, Jolanta, Starzyńska, Anna, Perdyan, Adrian, Sowa, Marek, Duchnowska, Renata, Biernat, Wojciech
Izdano u Cancers (Basel) (2021)

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients

od Winczura, Piotr, Sosińska-Mielcarek, Katarzyna, Duchnowska, Renata, Badzio, Andrzej, Lakomy, Joanna, Majewska, Hanna, Pęksa, Rafał, Pieczyńska, Beata, Radecka, Barbara, Dębska-Szmich, Sylwia, Adamowicz, Krzysztof, Biernat, Wojciech, Jassem, Jacek
Izdano u Pathol Oncol Res (2015)

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

od Szutowicz-Zielinska, Ewa, Konopa, Krzysztof, Kowalczyk, Anna, Suszko-Kazarnowicz, Malgorzata, Duchnowska, Renata, Szczesna, Aleksandra, Ratajska, Magdalena, Sowa, Aleksander, Limon, Janusz, Biernat, Wojciech, Burzykowski, Tomasz, Jassem, Jacek, Dziadziuszko, Rafal
Izdano u Oncotarget (2016)

SCDT-11. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

od Gril, Brunilde, Paranjape, Anurag N, Woditschka, Stephan, Hanson, Jeffrey, Wu, Xiaolin, Duchnowska, Renata, Brastianos, Priscilla K, Peer, Cody, Figg, William D, Pauly, Gary T, Schneider, Joel P, Steeg, Patricia S
Izdano u Neuro Oncol (2017)

TMIC-19. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

od Gril, Brunilde, Paranjape, Anurag N, Woditschka, Stephan, Hanson, Jeffrey, Wu, Xiaolin, Duchnowska, Renata, Brastianos, Priscilla K, Peer, Cody, Figg, William D, Pauly, Gary T, Schneider, Joel P, Steeg, Patricia
Izdano u Neuro Oncol (2017)

Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner

od Palmieri, Diane, Duchnowska, Renata, Woditschka, Stephan, Hua, Emily, Qian, Yongzhen, Biernat, Wojciech, Sosińska-Mielcarek, Katarzyna, Gril, Brunilde, Stark, Andreas, Hewitt, Stephen, Liewehr, David J, Steinberg, Seth M, Jassem, Jacek, Steeg, Patricia S
Izdano 2014

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain

od Duchnowska, Renata, Dziadziuszko, Rafał, Trojanowski, Tomasz, Mandat, Tomasz, Och, Waldemar, Czartoryska-Arłukowicz, Bogumiła, Radecka, Barbara, Olszewski, Wojciech, Szubstarski, Franciszek, Kozłowski, Wojciech, Jarosz, Bożena, Rogowski, Wojciech, Kowalczyk, Anna, Limon, Janusz, Biernat, Wojciech, Jassem, Jacek
Izdano 2012

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

od Duchnowska, Renata, Pęksa, Rafał, Radecka, Barbara, Mandat, Tomasz, Trojanowski, Tomasz, Jarosz, Bożena, Czartoryska-Arłukowicz, Bogumiła, Olszewski, Wojciech P., Och, Waldemar, Kalinka-Warzocha, Ewa, Kozłowski, Wojciech, Kowalczyk, Anna, Loi, Sherene, Biernat, Wojciech, Jassem, Jacek
Izdano u Breast Cancer Res (2016)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients

od Duchnowska, Renata, Jassem, Jacek, Goswami, Chirayu Pankaj, Dundar, Murat, Gökmen-Polar, Yesim, Li, Lang, Woditschka, Stephan, Biernat, Wojciech, Sosińska-Mielcarek, Katarzyna, Czartoryska-Arłukowicz, Bogumiła, Radecka, Barbara, Tomasevic, Zorica, Stępniak, Piotr, Wojdan, Konrad, Sledge, George W., Steeg, Patricia S., Badve, Sunil
Izdano u J Neurooncol (2015)

Alterations in Pericyte Subpopulations are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer

od Lyle, L. Tiffany, Lockman, Paul R., Adkins, Chris E., Mohammad, Afroz Shareef, Sechrest, Emily, Hua, Emily, Palmieri, Diane, Liewehr, David J., Steinberg, Seth M., Kloc, Wojciech, Izycka-Swieszewska, Ewa, Duchnowska, Renata, Nayyar, Naema, Brastianos, Priscilla K., Steeg, Patricia S., Gril, Brunilde
Izdano u Clin Cancer Res (2016)

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab

od Duchnowska, Renata, Sperinde, Jeff, Czartoryska-Arłukowicz, Bogumiła, Myśliwiec, Paulina, Winslow, John, Radecka, Barbara, Petropoulos, Christos, Demlova, Regina, Orlikowska, Marlena, Kowalczyk, Anna, Lang, Istvan, Ziółkowska, Barbara, Dębska-Szmich, Sylwia, Merdalska, Monika, Grela-Wojewoda, Aleksandra, Żawrocki, Anton, Biernat, Wojciech, Huang, Weidong, Jassem, Jacek
Izdano u Oncotarget (2017)

Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2(+) Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy

od Duchnowska, Renata, Biernat, Wojciech, Szostakiewicz, Barbara, Sperinde, Jeff, Piette, Fanny, Haddad, Mojgan, Paquet, Agnes, Lie, Yolanda, Czartoryska-Arłukowicz, Bogumiła, Wysocki, Piotr, Jankowski, Tomasz, Radecka, Barbara, Foszczyńska-Kłoda, Małgorzata, Litwiniuk, Maria, Dȩbska, Sylwia, Weidler, Jodi, Huang, Weidong, Buyse, Marc, Bates, Michael, Jassem, Jacek
Izdano 2012